{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:36:48Z","timestamp":1791247008073,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T00:00:00Z","timestamp":1228176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Extended\u2010release naltrexone (XR\u2010NTX) is a once\u2010a\u2010month injectable formulation for the treatment of alcohol dependence previously shown to reduce drinking and heavy drinking relative to placebo (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b12\">Garbutt et\u00a0al., 2005<\/jats:ext-link>). A 24\u2010week, randomized, double\u2010blind, placebo\u2010controlled study established the efficacy and safety of XR\u2010NTX in this patient population. In this report, the effect of XR\u2010NTX on quality of life (QOL) was examined.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Alcohol\u2010dependent patients were randomly assigned to receive XR\u2010NTX 380\u2003mg (<jats:italic>N<\/jats:italic>\u2003=\u2003205), XR\u2010NTX 190\u2003mg (<jats:italic>N<\/jats:italic>\u2003=\u2003210), or placebo (<jats:italic>N<\/jats:italic>\u2003=\u2003209), combined with a standardized psychosocial intervention. QOL was assessed using the Medical Outcomes Study 36\u2010item short\u2010form health survey, administered at baseline and at 4\u2010week intervals during 24\u2003weeks of treatment.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Compared with U.S. population norms, patients showed initial impairment in the health\u2010related QOL domains of mental health, social functioning, and problems with work or other daily activities due to emotional problems. Adherence to all 6 injections was 65% for XR\u2010NTX 190\u2003mg, 63% for XR\u2010NTX 380\u2003mg, and 64% for placebo. Generalized estimating equations analyses using an intention\u2010to\u2010treat sample revealed that XR\u2010NTX 380\u2003mg was associated with significantly greater improvements from baseline in mental health (<jats:italic>p<\/jats:italic>\u2003=\u20030.0496), social functioning (<jats:italic>p<\/jats:italic>\u2003=\u20030.010), general health (<jats:italic>p\u2003<\/jats:italic>=\u20030.048), and physical functioning (<jats:italic>p\u2003<\/jats:italic>=\u20030.028), compared with placebo. Linear regression analyses revealed that reductions from baseline in drinking (percentage of drinking days and percentage of heavy drinking days in the last 30\u2003days) were significantly (<jats:italic>p\u2003<\/jats:italic>&lt;\u20030.05) correlated with improvements in quality of life.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Extended\u2010release naltrexone 380\u2003mg in combination with psychosocial intervention was associated with improvements in QOL, specifically in the domains of mental health, social functioning, general health, and physical functioning.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2008.00843.x","type":"journal-article","created":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T18:59:56Z","timestamp":1228244396000},"page":"350-356","source":"Crossref","is-referenced-by-count":42,"title":["Effect of Extended\u2010Release Naltrexone (XR\u2010NTX) on Quality of Life in Alcohol\u2010Dependent Patients"],"prefix":"10.1111","volume":"33","author":[{"given":"Helen M.","family":"Pettinati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Gastfriend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2003"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00343.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00763.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952999809019617"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsas.2005.s15.119"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.4.5.515"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1614.2004.01469.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(00)00102-6"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008802711478"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)85143-8"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2006.67.147"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1617"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.09.008"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.02.004"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.3.221"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000134234.39303.17"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.9.905"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.63.1.133"},{"key":"e_1_2_7_20_1","volume-title":"Quality of Life in Mental Disorders","author":"Katschnig H","year":"2006"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02345.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011127"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.1.13"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00134-0"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1381.1999.09256.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1996.911014273.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000108652.73143.4B"},{"key":"e_1_2_7_28_1","volume-title":"The Global Burden of Disease","author":"Murray CJL","year":"1996"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e31814ce50d"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v19n01_06"},{"key":"e_1_2_7_31_1","first-page":"39","article-title":"Alcohol\u2010related morbidity and mortality","volume":"27","author":"Rehm J","year":"2003","journal-title":"Alcohol Res Health"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1999.60.653"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17870-2"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-0357-5_3"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1997.tb03855.x"},{"key":"e_1_2_7_36_1","volume-title":"Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach","author":"Volpicelli JR","year":"2001"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830200071010"},{"key":"e_1_2_7_38_1","volume-title":"How to Score Version 2 of the SF\u201036 Health Survey","author":"Ware J","year":"2000"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00884.x"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2008.00843.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2008.00843.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T13:20:50Z","timestamp":1697116850000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2008.00843.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,22]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1530-0277.2008.00843.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2008.00843.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,22]]}}}